A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Recruiting · NCT07235384 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 1 | 2026-08-07 | NCT07235384 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zai Lab (Shanghai) Co., Ltd. | 12 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aotearoa Clinical Trials | Auckland | New Zealand | 1 |
| Hangzhou First People's Hospital | Hangzhou | China | 14 |
| Momentum Auckland | Takapuna | New Zealand | 2 |
| Momentum Hamilton | Hamilton | New Zealand | 1 |
| Momentum Hutt Valley | Upper Hutt | New Zealand | 1 |
| Momentum Kapiti | Waikanae | New Zealand | 1 |
| Momentum Palmerston North | Palmerston North | New Zealand | 1 |
| Peking University Third Hospital | Beijing | China | 38 |
| Shandong Provincial Dermatology Hospital | Jinan | China | 2 |
| Shanghai Skin Disease Hospital | Shanghai | China | 2 |
| Skin Health Institute | Carlton | Australia | 1 |
| Veracity Clinical Research | Woolloongabba | Australia | 1 |